Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:2166-2174, doi:10.1016/j.jacc.2008.09.027
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartunek, J.
Right arrow Articles by Weinberg, E. O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bartunek, J.
Right arrow Articles by Weinberg, E. O.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: BIOMARKERS IN HEART FAILURE

Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load

Jozef Bartunek, MD, PhD*,{dagger},*, Leen Delrue, PhD*,{dagger}, Frederik Van Durme, MD*, Olivier Muller, MD, PhD*, Filip Casselman, MD, PhD{ddagger}, Bart De Wiest, RN§, Romaric Croes, MD||, Sofie Verstreken, MD*, Marc Goethals, MD*, Herbert de Raedt, MD*, Jaydeep Sarma, MD, PhD*, Lija Joseph, MD, Marc Vanderheyden, MD*,{dagger} and Ellen O. Weinberg, PhD,*

* Cardiovascular Center and Cardiovascular Research Center, OLV Hospital, Aalst, Belgium
{dagger} Translational Cardiology Unit, OLV Hospital, Aalst, Belgium
{ddagger} Department of Cardiovascular Surgery, OLV Hospital, Aalst, Belgium
§ Department of Pathology, OLV Hospital, Aalst, Belgium
|| Department of Pathology, St. Blasium Hospital, Dendermonde, Belgium
Boston Medical Center, Boston, Massachusetts

Manuscript received May 12, 2008; revised manuscript received August 26, 2008, accepted September 22, 2008.

* Reprint requests and correspondence: Dr. Jozef Bartunek, Cardiovascular Center and Cardiovascular Research Center, Moorselbaan 164, 9300 Aalst, Belgium (Email: jozef.bartunek{at}olvz-aalst.be).

* Dr. Ellen O. Weinberg, Boston Medical Center, EBRC Room 704, 650 Albany Street, Boston, Massachusetts 02118 (Email: eweinbe{at}bu.edu).

Objectives: This study was designed to investigate: 1) relationships between serum ST2 levels and hemodynamic/neurohormonal variables; 2) myocardial ST2 production; and the 3) expression of ST2, membrane-anchored ST2L, and its ligand, interleukin (IL)-33, in myocardium, endothelium, and leukocytes from patients with left ventricular (LV) pressure overload and congestive cardiomyopathy.

Background: Serum levels of ST2 are elevated in heart failure. The relationship of ST2 to hemodynamic variables, source of ST2, and expression of ST2L and IL-33 in the cardiovascular system are unknown.

Methods: Serum ST2 (pg/ml; median [25th, 75th percentile]) was measured in patients with LV hypertrophy (aortic stenosis) (n = 45), congestive cardiomyopathy (n = 53), and controls (n = 23). ST2 was correlated to N-terminal pro-brain natriuretic peptide, C-reactive protein, and hemodynamic variables. Coronary sinus and arterial blood sampling determined myocardial gradient (production) of ST2. The levels of ST2, ST2L, and IL-33 were measured (reverse transcriptase-polymerase chain reaction) in myocardial biopsies and leukocytes. The ST2 protein production was evaluated in human endothelial cells. The IL-33 protein expression was determined (immunohistochemistry) in coronary artery endothelium.

Results: The ST2 protein was elevated in aortic stenosis (103 [65, 165] pg/ml, p < 0.05) and congestive cardiomyopathy (194 [69, 551] pg/ml, p < 0.01) versus controls (49 [4, 89] pg/ml) and correlated with B-type natriuretic peptide (r = 0.5, p < 0.05), C-reactive protein (r = 0.6, p < 0.01), and LV end-diastolic pressure (r = 0.38, p < 0.03). The LV ST2 messenger ribonucleic acid was similar in aortic stenosis and congestive cardiomyopathy versus control (p = NS). No myocardial ST2 protein gradient was observed. Endothelial cells secreted ST2. The IL-33 protein was expressed in coronary artery endothelium. Leukocyte ST2L and IL-33 levels were highly correlated (r = 0.97, p < 0.001).

Conclusions: In human hypertrophy and failure, serum ST2 correlates with the diastolic load. Though the heart, endothelium, and leukocytes express components of ST2/ST2L/IL-33 pathway, the source of circulating serum ST2 is extra-myocardial.

Key Words: interleukins • ST2 • hypertrophy • heart failure • natriuretic peptides • endothelium-derived factors

Abbreviations and Acronyms
  AS = aortic stenosis
  AU = arbitrary units
  BNP = B-type natriuretic peptide
  CCM = congestive cardiomyopathy
  EDP = end-diastolic pressure
  hsCRP = high sensitivity C-reactive protein
  IL = interleukin
  LV = left ventricular
  mRNA = messenger ribonucleic acid
  NT-proBNP = N-terminal pro-brain natriuretic peptide


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A29. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement